GB9713469D0 - Neuronal stem cell gene - Google Patents

Neuronal stem cell gene

Info

Publication number
GB9713469D0
GB9713469D0 GBGB9713469.6A GB9713469A GB9713469D0 GB 9713469 D0 GB9713469 D0 GB 9713469D0 GB 9713469 A GB9713469 A GB 9713469A GB 9713469 D0 GB9713469 D0 GB 9713469D0
Authority
GB
United Kingdom
Prior art keywords
stem cell
cell gene
neuronal stem
neuronal
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9713469.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Priority to GBGB9713469.6A priority Critical patent/GB9713469D0/en
Publication of GB9713469D0 publication Critical patent/GB9713469D0/en
Priority to AU82238/98A priority patent/AU737409B2/en
Priority to EP98932288A priority patent/EP0990046A2/en
Priority to PCT/GB1998/001862 priority patent/WO1999000516A2/en
Priority to CA002295305A priority patent/CA2295305A1/en
Priority to JP50537999A priority patent/JP2002508666A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0618Cells of the nervous system
    • C12N5/0623Stem cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60Transcription factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB9713469.6A 1997-06-25 1997-06-25 Neuronal stem cell gene Pending GB9713469D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9713469.6A GB9713469D0 (en) 1997-06-25 1997-06-25 Neuronal stem cell gene
AU82238/98A AU737409B2 (en) 1997-06-25 1998-06-25 Neuronal stem cell gene
EP98932288A EP0990046A2 (en) 1997-06-25 1998-06-25 Neuronal stem cell gene
PCT/GB1998/001862 WO1999000516A2 (en) 1997-06-25 1998-06-25 Neuronal stem cell gene
CA002295305A CA2295305A1 (en) 1997-06-25 1998-06-25 Neuronal stem cell gene
JP50537999A JP2002508666A (ja) 1997-06-25 1998-06-25 神経幹細胞遺伝子

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713469.6A GB9713469D0 (en) 1997-06-25 1997-06-25 Neuronal stem cell gene

Publications (1)

Publication Number Publication Date
GB9713469D0 true GB9713469D0 (en) 1997-09-03

Family

ID=10814932

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9713469.6A Pending GB9713469D0 (en) 1997-06-25 1997-06-25 Neuronal stem cell gene

Country Status (6)

Country Link
EP (1) EP0990046A2 (ja)
JP (1) JP2002508666A (ja)
AU (1) AU737409B2 (ja)
CA (1) CA2295305A1 (ja)
GB (1) GB9713469D0 (ja)
WO (1) WO1999000516A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828383D0 (en) * 1998-12-22 1999-02-17 Medical Res Council Cell lineage markers
US7312081B2 (en) 2000-05-11 2007-12-25 The Trustees Of Columbia University In The City Of New York Genetic demonstration of requirement for nkx6.1, nkx2.2 and nkx6.2 in ventral neuron generation
US6955802B1 (en) 2000-05-11 2005-10-18 The Trustees Of Columbia University In The City Of New York Homeodomain protein code specifying progenitor cell identify and neuronal fate in the ventral neural tube
US7393686B1 (en) 2000-05-11 2008-07-01 Trustees Of Columbia University In The City Of New York Genetic demonstration of requirement for NKX6.1 and NKX2.2 in ventral neuron generation
EP1315794A4 (en) * 2000-09-01 2005-01-26 Univ Columbia GENETIC DEMONSTRATION OF THE NEED FOR NKX6.1, NKX2.2 AND NKX6.2 FOR THE PRODUCTION OF NEURONES VENTRAUX

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639618A (en) * 1994-05-13 1997-06-17 Plurion, Inc. Method of isolating a lineage specific stem cell in vitro
US5753505A (en) * 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof

Also Published As

Publication number Publication date
AU737409B2 (en) 2001-08-16
WO1999000516A3 (en) 1999-03-18
AU8223898A (en) 1999-01-19
CA2295305A1 (en) 1999-01-07
WO1999000516A2 (en) 1999-01-07
EP0990046A2 (en) 2000-04-05
JP2002508666A (ja) 2002-03-19

Similar Documents

Publication Publication Date Title
SG63814A1 (en) Thin type cell
IL142748A0 (en) Embryonic stem cells
EP0986635A4 (en) SERUM SUBSTITUTE FOR EMBRYONIC STEM CELLS
GB9518220D0 (en) Checkpoint gene
GB9713346D0 (en) Valve assemblies
EP1115841A4 (en) STABLE CELL LINES FROM NEURAL STEM CELLS
EP0969014A4 (en) BETA-KETOACYL-ACP-SYNTHELASE II ENZYME AND GENE CODING FOR IT
PL340374A1 (en) Tanatin encoding gene
GB9713469D0 (en) Neuronal stem cell gene
IL120445A0 (en) Biosensor for cells
GB9705744D0 (en) Methods for selecting cells and their uses
GB9727047D0 (en) Improved ball-type valve
EP1038957A4 (en) GENE TSA305
GB9724828D0 (en) Gene
PL340754A1 (en) Method activating haemoblast-type stem cells
GB9706469D0 (en) Genetic method
EP1062228A4 (en) PLASMINOGEN-RELATED B GENE POLYPEPTIDES
GB9703890D0 (en) Valves
AU6897498A (en) Human neuronal cell line
GB9722238D0 (en) Gene
GB9709003D0 (en) Gene
GB9718029D0 (en) Gene
ZA9811751B (en) Electrowinning cell
GB9700839D0 (en) Valve arrangement
GB9721786D0 (en) Protein associated with cells possessing an altered phenotype